Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 122.06
- Piotroski Score 2.00
- Grade Buy
- Symbol (SMMT)
- Company Summit Therapeutics Inc.
- Price $18.99
- Changes Percentage (3.09%)
- Change $0.57
- Day Low $18.50
- Day High $19.44
- Year High $33.89
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. It also offers SMT-738, for combating multidrug resistant infections primarily carbapenem-resistant Enterobacteriaceae infections; and DDS-04 series for the potential treatment of infections caused by the Enterobacteriaceae. The company was founded in 2003 and is based in Cambridge, Massachusetts.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/18/2025
- Fiscal Year End N/A
- Average Stock Price Target $36.00
- High Stock Price Target $45.00
- Low Stock Price Target $23.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.38
- Trailing P/E Ratio 20.32
- Forward P/E Ratio 20.32
- P/E Growth 20.32
- Net Income $-614,928,000
Income Statement
Quarterly
Annual
Latest News of SMMT
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Auto Trader, SMMT and ChargeUK team up to combat EV misconceptions
Auto Trader, SMMT, and ChargeUK have joined forces to dispel myths about electric vehicles and provide accurate information to consumers. The initiative aims to address concerns about EVs and encourag...
By Yahoo! Finance | 4 days ago -
UK new car sales fall in October 2024, reports SMMT
In October 2024, the UK car market saw a 6% decline in registrations, with petrol and diesel vehicles leading the drop. However, battery-electric vehicles grew by 24.5%. Despite EV progress, market co...
By Yahoo! Finance | 2 weeks ago -
Is Summit Therapeutics Inc. (SMMT) the Best QQQ Stock to Buy According to Analysts?
Insider Monkey has identified Summit Therapeutics Inc. as a top QQQ stock pick based on analysts' recommendations. The company focuses on developing innovative therapies for rare genetic diseases, wit...
By Yahoo! Finance | 1 month ago
